NCT04862793

Brief Summary

In a cluster-randomized study compare if feedback from two computerized feedback systems doing a colonoscopy (CoPS and CoRS) can improve the adenoma detection rate and decrease patient discomfort.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for not_applicable colorectal-cancer

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable colorectal-cancer

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 21, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 28, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

April 28, 2021

Status Verified

April 1, 2021

Enrollment Period

2.5 years

First QC Date

April 21, 2021

Last Update Submit

April 23, 2021

Conditions

Keywords

ColonoscopyAdenoma Detection RateComputerized Feedback

Outcome Measures

Primary Outcomes (2)

  • Feedback from CoRS results in change in Adenoma Detection Rate for individual operators and for the department as a whole.

    The Adenoma Detection Rate of an operator is correlated to patient survival of colorectal cancer. A low Adenoma Detection Rate is correlated with a higher occurrence of interval cancer. Increasing the Adenoma Detection Rate will result in a more beneficial screening program with more cancers being caught in an earlier state and thereby increase patient survival.

    Baseline (pre-intervention) and with the end of each time cluster (month 8, 12, 16, 18). The intervention will be at different time clusters for the three participating hospitals, and therefore the baseline sampling period will be different.

  • Feedback from CoPS results in change in patient discomfort.

    Patient discomfort will be assessed by a post-procedure questionnaire. We will examine the correlation between the intervention and patient discomfort, and assess if more procedures can be completed due to less patient discomfort using the intervention.

    Baseline (pre-intervention) and with the end of each time cluster (month 8, 12, 16, 18). The intervention will be at different time clusters for the three participating hospitals, and therefore the baseline sampling period will be different.

Secondary Outcomes (1)

  • Make an immediate measure to assess the quality of individual colonoscopy performance.

    On data collection completion, estimated December 2023

Study Arms (2)

Feedback

EXPERIMENTAL

Feedback system through CoPS and CoRS

Device: Colonoscopy Progression Score (CoPS)Device: Colonoscopy Retraction Score (CoRS)

Standard procedure

NO INTERVENTION

Performing the standard procedure in accordance with the departments usual conduct.

Interventions

The Colonoscopy Progression Score consists of five different aspects: Travel length, Tip progression, chase efficiency, shaft movement without tip progression and looping.

Feedback

The Colonoscopy Retraction Score consists of three different aspects: Tip Retraction, Retraction Efficiency, and Retraction Distance.

Feedback

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Admitted for a screening colonoscopy through the Danish National Screening Program for Colorectal Cancer.

You may not qualify if:

  • In cases were the cecum is not reached.
  • Unsatisfactory bowel preparation which results in admission for a new procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Kristoffer Mazanti Cold, MD

    PhD-alumni

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kristoffer Mazanti Cold, MD

CONTACT

Lars Konge, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: A randomized controlled cluster trial following a stepped-wedge randomization.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 21, 2021

First Posted

April 28, 2021

Study Start

June 1, 2021

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

April 28, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will share

all IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
At end of data collection (December 2023) and for the following 5 years.
Access Criteria
On request to the primary investigator with a useful scientific purpose.